WW announced on Thursday that it will be laying off employees and cutting costs to the tune of $100 million per year.
Novo Nordisk scored approval to sell its Wegovy weight loss drug in China. That’s a big win, but competitors will soon flood in.
A loophole lets the company create a back-door offering of a generic drug before the patents of Novo Nordisk and Eli Lilly expire.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
A new survey finds evidence that “the drugs have a meaningful impact on consumer behavior and spending on groceries and restaurants.”
A GLP-1 medication from French drugmaker Sanofi — similar to Ozempic — was found to slow Parkinson’s in a small mid-stage trial.
The partnership is going nationwide after a successful run at 160 McDonald’s locations across Kentucky.
Facebook and other social media platforms are the subject of a probe by federal prosecutors into available medications.